CTOs on the Move

Xealth

www.xealth.io

 
Xealth enables healthcare teams to order digital content and services as easily as they do medications today.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Xealth raised $11M on 03/27/2019

Similar Companies

Salient Surgical Technologies

Salient Surgical Technologies, Inc. is a Portsmouth, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Health Care Excel Inc

Health Care Excel Inc is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PRS Network

PRS Network is a Larkspur, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MedImpact

MedImpact Healthcare Systems, Inc. is the nation’s largest privately held pharmacy benefit management (PBM) company, serving health plans, self-funded employers and government entities. Our business model is unique: avoiding conflicts of interest by not dispensing drugs. MedImpact is focused on effectively managing client pharmacy benefits to facilitate better trend management and improved outcomes. We work with clients to direct prescribing to the lowest-net-cost, medically appropriate drug. Our number one goal is client satisfaction by providing flexible solutions and consumer-driven products with a focus on lowest net cost and quality outcomes.

RaNA Therapeutics

RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.